Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting : JCR: Journal of Clinical Rheumatology

Secondary Logo

Journal Logo

Advanced Search
Concise Reports

Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting

Kotecha, Jalpa MRCP∗; Fardeen, Kazi Mashfia MBBS†; Mirzazadeh, Mehdi MRCP, FRCPath†

Author Information

From the ∗King's College Hospital, London

†St Helier Hospital, Carshalton, England.

The authors declare no conflict of interest.

Correspondence: Kazi Mashfia Fardeen, MBBS, Department of Rheumatology, St Helier Hospital, Wrythe Lane, Carshalton SM5 1AA, England. E-mail: [email protected].

JCR: Journal of Clinical Rheumatology 29(2):p 101-104, March 2023. | DOI: 10.1097/RHU.0000000000001894
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid